Published in Neuroradiology on July 13, 2010
Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T. Cancer Imaging (2012) 1.34
Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging. Neuroradiology (2011) 1.09
The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives. Cancer Imaging (2014) 1.03
Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion. Neuroradiology (2015) 0.86
The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis. Cancer Imaging (2014) 0.85
Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters. J Neurooncol (2014) 0.79
Novel treatment strategies for brain tumors and metastases. Pharm Pat Anal (2014) 0.77
The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions. Oncotarget (2016) 0.75
Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging. PLoS One (2016) 0.75
Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle. PLoS One (2017) 0.75
Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors. PLoS One (2016) 0.75
Cancer statistics, 1999. CA Cancer J Clin (1999) 9.18
The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol (2002) 8.62
A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med (1990) 7.92
Angiogenesis. Annu Rev Med (2006) 6.94
High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med (1996) 6.90
Angiogenesis in brain tumours. Nat Rev Neurosci (2007) 6.82
Imaging of angiogenesis: from microscope to clinic. Nat Med (2003) 5.51
Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol (2003) 5.28
Perfusion imaging with NMR contrast agents. Magn Reson Med (1990) 5.01
Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol (2006) 4.09
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol (2004) 3.56
Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology (2008) 3.47
The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol (2002) 2.27
Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol (2006) 2.27
High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology (2002) 2.22
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15
The vascular basement membrane as "soil" in brain metastasis. PLoS One (2009) 1.95
Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology (2002) 1.90
Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst (2005) 1.76
Biology of angiogenesis and invasion in glioma. Neurotherapeutics (2009) 1.61
Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol (2002) 1.55
Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol (1997) 1.53
Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol (2002) 1.53
Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol (2006) 1.37
Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology (2006) 1.36
Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging (2006) 1.32
Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology (2004) 1.30
Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg (1999) 1.29
Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. AJNR Am J Neuroradiol (2008) 1.29
Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res (2003) 1.26
The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections. Cancer (1987) 1.20
Perfusion MR imaging of brain tumors. Top Magn Reson Imaging (2004) 1.18
Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas. Curr Opin Neurol (2008) 1.16
Changes of the blood-brain barrier in experimental metastatic brain tumors. J Neurosurg (1983) 1.13
Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology (2006) 1.10
Hematogenous metastases of the human brain--characteristics of peritumoral brain changes: a review. J Neurooncol (1997) 1.06
Angiogenesis in gliomas: imaging and experimental therapeutics. Brain Pathol (2005) 1.06
Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci (2009) 1.04
Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol (2001) 1.04
Neuroradiological assessment of newly diagnosed glioblastoma. J Neurooncol (2008) 1.03
Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging (2005) 1.01
Current management of metastatic brain disease. Neurotherapeutics (2009) 1.01
Capillary ultrastructure in human metastatic brain tumors. J Neurosurg (1979) 1.00
A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MR. Neuroimage (2007) 0.99
Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner. Diagn Interv Radiol (2009) 0.98
The biologic basis of in vivo angiogenesis imaging. Front Biosci (2007) 0.98
Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol (2008) 0.97
Mechanisms of tumor-related brain edema. Neurosurg Focus (2007) 0.95
Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol (1997) 0.95
Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med (1995) 0.93
Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol (2005) 0.92
Brain metastases. Neurol Clin (2007) 0.86
Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma. AJNR Am J Neuroradiol (2008) 0.85
Proton MRS of the peritumoral brain. J Neurol Sci (2004) 0.84
T1 effects in sequential dynamic susceptibility contrast experiments. J Magn Reson (1998) 0.82
Repeat cerebral blood volume assessment with first-pass MR imaging. J Magn Reson Imaging (1994) 0.81
A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model. Acta Neuropathol (1985) 0.80
Brain metastatic lesions. Mayo Clin Proc (1994) 0.79
Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol (2002) 0.78
Automatic vessel removal in gliomas from dynamic susceptibility contrast imaging. Magn Reson Med (2009) 0.77
Neuroimaging of metastatic brain disease. Neurosurgery (2005) 0.77
High-grade gliomas in patients with prior systemic malignancies. Cancer (2002) 0.76
MR imaging of brain tumors: toward physiologic imaging. AJNR Am J Neuroradiol (2000) 0.75
[Ultrastructure of capillary permeability in human brain tumor--Part 6: Metastatic brain tumor with brain edema]. No Shinkei Geka (1988) 0.75
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiol (2010) 2.26
Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry (2010) 1.73
Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res (2002) 1.26
Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts. Magn Reson Med (2004) 1.09
Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res (2002) 1.08
A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal window chamber. Microvasc Res (2007) 1.02
Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother Oncol (2005) 0.99
Marine n-3 fatty acids promote size reduction of visceral adipose depots, without altering body weight and composition, in male Wistar rats fed a high-fat diet. Br J Nutr (2009) 0.94
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur J Radiol (2010) 0.93
Tumor-line specific pO(2) fluctuations in human melanoma xenografts. Int J Radiat Oncol Biol Phys (2004) 0.91
Characterization of Streptococcus constellatus strains recovered from a brain abscess and periodontal pockets in an immunocompromised patient. J Periodontol (2004) 0.87
Intravascular large B-cell lymphoma presenting as cerebellar and cerebral infarction. Arch Neurol (2007) 0.84
Associations between variants near a monoaminergic pathways gene (PHOX2B) and amygdala reactivity: a genome-wide functional imaging study. Twin Res Hum Genet (2012) 0.81
Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures. Acta Neurochir (Wien) (2013) 0.81
Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging (2005) 0.78
Arousal Modulates Activity in the Medial Temporal Lobe during a Short-Term Relational Memory Task. Front Hum Neurosci (2012) 0.76